Funding for this research was provided by:
Association Française contre les Myopathies
Ile-de-France Regional Health Agency
Received: 14 July 2020
Accepted: 9 October 2020
First Online: 27 November 2020
Ethics approval and consent to participate
: This study was approved by an ethical committee (ID RCB: 2018-A022311-54) and referenced on ClinicalTrials.gov (NCT03832231). Informed consent was obtained from all patients or their relatives.
: Not applicable.
: JLG is a scientific consultant for Supersonic Imagine, Aix-en-Provence, France. MD received personal fees from Lungpacer Medical Inc., Vancouver, Canada. AD reports personal fees from Medtronic, grants, personal fees and non-financial support from Philips, personal fees from Baxter, personal fees from Hamilton, personal fees and non-financial support from Fisher & Paykel, grants from French Ministry of Health, personal fees from Getinge, grants, personal fees and non-financial support from Respinor, grants, personal fees and non-financial support from Lungpacer, personal fees from Lowenstein, outside the submitted work. The remaining authors do not declare any competing interest.